|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 220.75 USD | +4.56% |
|
+6.81% | +20.87% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 285.42 | +29.3% | 21 | |||||||
| 849.32 | +8.68% | 27 | |||||||
| 119.56 | -16.96% | 18 | |||||||
| 123.23 | +2.83% | 17 | |||||||
| 1,967,520 | +39.05% | 25 | |||||||
| 285 | +38.62% | 19 | |||||||
| 237.19 | +9.23% | 31 | |||||||
| 127.74 | +5.16% | 23 | |||||||
| 110.32 | +37.46% | 28 | |||||||
| 500.92 | +14.26% | 12 | |||||||
| 109.1 | +50.6% | 21 | |||||||
| 394,615.38 | +47.24% | 6 | |||||||
| 91.42 | +39.19% | 26 | |||||||
| 385 | +10.95% | 8 | |||||||
| 106.25 | -16.48% | 12 | |||||||
| 14.76 | +50.26% | 12 | |||||||
| 98 | +28.49% | 8 | |||||||
| 83 | +25.11% | 2 | |||||||
| - | - | 60.94 | +60.07% | 1 | |||||
| - | - | 32.4 | +23.29% | 1 | |||||
| Average | 118,287.75 | +24.32% | 16 | ||||||
| Weighted average by Cap. | 211,911.75 | +17.15% | 20 |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















